Cancer type |
Author |
% methylation. |
Multiple Myeloma (26) |
Margaret et al |
67% |
Paediatric AML (25) |
Ekmekd et al |
70% |
Adult AML (25) |
Ekmekd et al |
55% |
Childhood ALL (27) |
Gutierrez et al |
23.2% |
B cell lymphoma (24) |
Sung Kim et al |
60.9% |
Ocular adnexal lymphoma (28) |
Ho-Kyung et al |
94.3% |
Head and neck cancer (30) |
Masayuki et al |
23.8% |
Myelodysplastic syndrome (29) |
J Qian et al |
62.7% |
Hematological malignancies. (31) |
Tamer et al |
28% |
CML (32) |
Eisuke et al |
6% |
CML (33) |
J Qian et al |
51% |
Our study |
|
45.5% |
|